Journal
VIRUSES-BASEL
Volume 10, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/v10050267
Keywords
Hepatitis B virus; intracellular drug delivery; liver targeting; hepatocyte; asialoglycoprotein receptor; nanoparticles; cell-penetrating peptides
Categories
Ask authors/readers for more resources
Chronic hepatitis B virus (HBV) infection poses a significant health challenge due to associated morbidity and mortality from cirrhosis and hepatocellular cancer that eventually results in the breakdown of liver functionality. Nanotechnology has the potential to play a pivotal role in reducing viral load levels and drug-resistant HBV through drug targeting, thus reducing the rate of evolution of the disease. Apart from tissue targeting, intracellular delivery of a wide range of drugs is necessary to exert a therapeutic action in the affected organelles. This review encompasses the strategies and techniques that have been utilized to target the HBV-infected nuclei in liver hepatocytes, with a significant look at the new insights and most recent advances in drug carriers and their role in anti-HBV therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available